509 related articles for article (PubMed ID: 11908942)
1. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
Wang D; Hill JA; Cairns E; Bell DA
J Autoimmun; 2002 Mar; 18(2):95-103. PubMed ID: 11908942
[TBL] [Abstract][Full Text] [Related]
2. Immunopathogenesis of collagen arthritis.
Brand DD; Kang AH; Rosloniec EF
Springer Semin Immunopathol; 2003 Aug; 25(1):3-18. PubMed ID: 12904888
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
4. Breaking T cell tolerance against self type II collagen in HLA-DR4-transgenic mice and development of autoimmune arthritis.
Batsalova T; Dzhambazov B; Merky P; Bäcklund A; Bäcklund J
Arthritis Rheum; 2010 Jul; 62(7):1911-20. PubMed ID: 20309862
[TBL] [Abstract][Full Text] [Related]
5. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
Rosloniec EF; Brand DD; Myers LK; Esaki Y; Whittington KB; Zaller DM; Woods A; Stuart JM; Kang AH
J Immunol; 1998 Mar; 160(6):2573-8. PubMed ID: 9510154
[TBL] [Abstract][Full Text] [Related]
6. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
[TBL] [Abstract][Full Text] [Related]
7. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
[TBL] [Abstract][Full Text] [Related]
8. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
9. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.
Doncarli A; Stasiuk LM; Fournier C; Abehsira-Amar O
Eur J Immunol; 1997 Jun; 27(6):1451-8. PubMed ID: 9209498
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
Mauri C; Feldmann M; Williams RO
Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
[TBL] [Abstract][Full Text] [Related]
12. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis.
Bäcklund J; Treschow A; Bockermann R; Holm B; Holm L; Issazadeh-Navikas S; Kihlberg J; Holmdahl R
Eur J Immunol; 2002 Dec; 32(12):3776-84. PubMed ID: 12516572
[TBL] [Abstract][Full Text] [Related]
13. Epicutaneous immunization with type II collagen inhibits both onset and progression of chronic collagen-induced arthritis.
Strid J; Tan LA; Strobel S; Londei M; Callard R
PLoS One; 2007 Apr; 2(4):e387. PubMed ID: 17440622
[TBL] [Abstract][Full Text] [Related]
14. T helper subset involvement in two high antibody responder lines of mice (Biozzi mice): HI (susceptible) and HII (resistant) to collagen-induced arthritis.
De Franco M; Gille-Perramant MF; Mevel JC; Couderc J
Eur J Immunol; 1995 Jan; 25(1):132-6. PubMed ID: 7843223
[TBL] [Abstract][Full Text] [Related]
15. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
17. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
[TBL] [Abstract][Full Text] [Related]
18. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM
Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
[TBL] [Abstract][Full Text] [Related]
19. Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs.
Chu CQ; Londei M
J Immunol; 1996 Sep; 157(6):2685-9. PubMed ID: 8805674
[TBL] [Abstract][Full Text] [Related]
20. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis.
Chu CQ; Londei M
J Autoimmun; 1999 Feb; 12(1):35-42. PubMed ID: 10028020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
